Table 3.
Univariate logistic regression analysis for the case group.
| Variables | Ineffective group (n = 32) | Effective group (n = 15) | OR | 95%CI | P-value |
|---|---|---|---|---|---|
| Age of onset | 38.0 (31.0, 53.3) | 33.0 (27.0,53.0) | 0.990 | 0.948–1.034 | 0.657 |
| Males: Females | 25:7 | 10:5 | 1.786 | 0.457–6.971 | 0.404 |
| Time to treatment (days) | 15.0 (7.3,24.5) | 4.0 (3.0,11.0) | 0.853 | 0.758–0.959 | 0.008* |
| Initial PTA | 61.4 ± 3.7 | 61.8 ± 6.8 | 1.001 | 0.973–1.029 | 0.955 |
| Final PTA | 57.9 ± 3.9 | 34.8 ± 6.6 | 0.954 | 0.923–0.988 | 0.007* |
| Hypertension | 29 (90.6%) | 13 (86.7%) | 1.487 | 0.221–9.993 | 0.683 |
| Vertigo | 21 (65.6%) | 10 (66.7%) | 0.955 | 0.261–3.495 | 0.944 |
| Tinnitus | 2 (6.3%) | 3 (20%) | 0.267 | 0.039–1.801 | 0.175 |
| Aural fullness | 8 (25.0%) | 3 (20%) | 1.333 | 0.298–5.957 | 0.706 |
| Vestibular dysfunction | 25 (78.1%) | 10 (66.7%) | 1.786 | 0.457–6.971 | 0.404 |
| Thyroid dysfunction | 27 (84.4%) | 12 (80%) | 1.350 | 0.277–6.585 | 0.711 |
| Inner ear MRI (+) | 25 (78.1%) | 10 (66.7%) | 1.786 | 0.457–6.971 | 0.404 |
| Blood index | |||||
| NLR | 1.9 (1.4, 2.5) | 1.7 (1.3,2.5) | 0.844 | 0.528–1.351 | 0.481 |
| MLR | 0.19 (0.14,0.29) | 0.19 (0.16,0.33) | 0.581 | 0.064–5.250 | 0.629 |
| PLR | 118.3 (87.6, 140.0) | 117.2 (97.2, 134.9) | 1.007 | 0.993–1.020 | 0.331 |
| TBIL (μmol/L) | 13.1 (10.6, 16.3) | 13.1 (10.7, 15.9) | 0.965 | 0.847–1.100 | 0.597 |
| IBIL (μmol/L) | 9.2 (7.4, 11.5) | 9.8 (7.7, 11.1) | 0.963 | 0.813–1.141 | 0.666 |
| SOD (U/mL) | 157.5 (147.5, 193.3) | 156.0 (133.0, 176.0) | 0.989 | 0.969–1.010 | 0.305 |
| Fibrinogen (g/L) | 2.3 (2.1, 2.7) | 2.4 (1.9, 2.8) | 0.809 | 0.313–2.091 | 0.662 |
| Glu (mmol/L) | 4.9 (4.7, 5.3) | 4.7 (4.1, 5.2) | 0.507 | 0.186–1.384 | 0.185 |
| TG (mmol/L) | 1.3 (0.8, 1.6) | 1.5 (0.9,1.8) | 0.867 | 0.429–1.751 | 0.690 |
| CH (mmol/L) | 4.9 ± 0.2 | 4.7 ± 0.3 | 0.818 | 0.412–1.623 | 0.565 |
| HDL (mmol/L) | 1.3 (1.1, 1.5) | 1.2 (0.9, 1.7) | 0.401 | 0.049–3.302 | 0.396 |
| LDL (mmol/L) | 2.9 ± 0.1 | 2.9 ± 0.2 | 0.995 | 0.460–2.153 | 0.990 |
| Hcy (μmol/L) | 10.7 (8.3, 14.6) | 11.5 (7.5, 25.1) | 1.064 | 0.979–1.156 | 0.142 |
PTA, pure-tone average; NLR, neutrophil lymphocyte ratio; MLR, monocyte lymphocyte ratio; PLR, platelet lymphocyte ratio; TBIL, total bilirubin levels; IBIL, indirect bilirubin; SOD, superoxide dismutase; Glu, glucose; TG, triglyceride; CH, cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Hcy, homocysteine.
*P < 0.05.